FGF21 and obesity disorder: Studies conducted in a UCP1/FGF21 double knockout (dKO) model have demonstrated a full reversal of obesity resistance in dKO mice by inhibiting the metabolic reprogramming of WAT genes responsible for enhanced lipid and oxidative metabolism.29